{"id":"https://openalex.org/W3086776284","doi":null,"title":"Sphingosine 1-Phosphate Receptor Modulators as a Potential Treatment Option in COVID-19 Induced Acute Respiratory Distress Syndrome: Mechanistic Insights and Benefit-Risk Assessment","display_name":"Sphingosine 1-Phosphate Receptor Modulators as a Potential Treatment Option in COVID-19 Induced Acute Respiratory Distress Syndrome: Mechanistic Insights and Benefit-Risk Assessment","publication_year":2020,"publication_date":"2020-01-01","ids":{"openalex":"https://openalex.org/W3086776284","mag":"3086776284"},"language":"en","primary_location":{"id":"mag:3086776284","doi":null,"is_oa":false,"landing_page_url":"https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/es/covidwho-710401","pdf_url":null,"source":{"id":"https://openalex.org/S162635963","display_name":"European Journal of Neurology","issn_l":"1351-5101","issn":["1351-5101","1468-1331"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Neurology","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028955605","display_name":"Thomas Hach","orcid":"https://orcid.org/0000-0002-2229-1545","observed_orcids":["https://orcid.org/0000-0002-2229-1545"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Hach","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2229-1545","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073808545","display_name":"Kasra Shakeri\u2010Nejad","orcid":"https://orcid.org/0000-0001-5923-5953","observed_orcids":["https://orcid.org/0000-0001-5923-5953"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kasra Shakeri\u2010Nejad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111654401","display_name":"Marc Bigaud","orcid":"https://orcid.org/0000-0002-1168-5311","observed_orcids":["https://orcid.org/0000-0002-1168-5311"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc Bigaud","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1168-5311","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038011784","display_name":"Frank Dahlke","orcid":"https://orcid.org/0000-0003-3333-6291","observed_orcids":["https://orcid.org/0000-0003-3333-6291"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank Dahlke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3333-6291","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023107242","display_name":"M. De Micco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. De Micco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016141380","display_name":"Olivier P\u00e9tricoul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olivier P\u00e9tricoul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027149692","display_name":"Gerard J. Graham","orcid":"https://orcid.org/0000-0002-7801-204X","observed_orcids":["https://orcid.org/0000-0002-7801-204X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerard J. Graham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012126889","display_name":"Daniela Piani-Meier","orcid":"https://orcid.org/0000-0003-0890-9422","observed_orcids":["https://orcid.org/0000-0003-0890-9422"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Piani-Meier","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0890-9422","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ruth Nat\u00e1lia Teresa Turrini","orcid":"https://orcid.org/0000-0002-4910-7672","observed_orcids":["https://orcid.org/0000-0002-4910-7672"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruth Nat\u00e1lia Teresa Turrini","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4910-7672","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080557819","display_name":"Volker Brinkmann","orcid":"https://orcid.org/0000-0003-4735-3682","observed_orcids":["https://orcid.org/0000-0003-4735-3682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Volker Brinkmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4735-3682","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062403608","display_name":"Ferdinando Nicoletti","orcid":"https://orcid.org/0000-0003-0917-443X","observed_orcids":["https://orcid.org/0000-0003-0917-443X","https://orcid.org/0000-0003-3366-7269","https://orcid.org/0000-0002-4570-8462"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ferdinando Nicoletti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4100,"currency":"USD","value_usd":4100},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":null,"first_page":"1306","last_page":"1306"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.6509000062942505,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.6509000062942505,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.28029999136924744,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10322","display_name":"Respiratory Support and Mechanisms","score":0.02800000086426735,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8130000233650208},{"id":"https://openalex.org/keywords/acute-respiratory-distress-syndrome","display_name":"acute respiratory distress syndrome","score":0.9150000214576721},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.8539999723434448},{"id":"https://openalex.org/keywords/sphingosine-1-phosphate-receptor-modulator","display_name":"sphingosine-1-phosphate receptor modulator","score":0.906000018119812},{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":1.0},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9589999914169312},{"id":"https://openalex.org/keywords/protein-phosphatase-2a","display_name":"protein phosphatase 2A","score":0.6790000200271606},{"id":"https://openalex.org/keywords/th17-cells","display_name":"Th17 cells","score":0.9279999732971191},{"id":"https://openalex.org/keywords/c-abl-kinase","display_name":"c-Abl kinase","score":0.9620000123977661},{"id":"https://openalex.org/keywords/lymphocyte-count","display_name":"lymphocyte count","score":0.746999979019165},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.8960000276565552},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.5929999947547913},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.9619119167327881},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.795534610748291},{"id":"https://openalex.org/C2776348555","wikidata":"https://www.wikidata.org/wiki/Q344873","display_name":"ARDS","level":3,"score":0.6293693780899048},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.45582354068756104},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40960589051246643},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.40669307112693787},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38677793741226196},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2556876540184021},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.18448081612586975},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.15151092410087585},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.14415636658668518},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3086776284","doi":null,"is_oa":false,"landing_page_url":"https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/es/covidwho-710401","pdf_url":null,"source":{"id":"https://openalex.org/S162635963","display_name":"European Journal of Neurology","issn_l":"1351-5101","issn":["1351-5101","1468-1331"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Neurology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310565213","https://openalex.org/W4396645071","https://openalex.org/W3088848811","https://openalex.org/W4312222771","https://openalex.org/W3094748410","https://openalex.org/W4309775636","https://openalex.org/W3022213434","https://openalex.org/W4295858018","https://openalex.org/W3025839397","https://openalex.org/W4317105188"],"abstract_inverted_index":{"Introduction:":[0],"Coronavirus":[1],"disease":[2],"2019":[3],"(COVID-19)":[4],"is":[5,48,66],"a":[6,11,44,221,245],"viral":[7],"infection":[8],"caused":[9],"by":[10,104],"newly":[12],"emergent":[13],"coronavirus,":[14],"SARS-CoV-2,":[15],"primarily":[16],"affecting":[17],"the":[18,72,101,109,116,162,212],"respiratory":[19,37],"tract":[20],"Maladjusted":[22],"immune":[23,183,188,251],"responses,":[24],"e":[25],"g":[26],"cytokine":[28,145],"release":[29,146],"syndrome,":[30],"may":[31,107,243],"result":[32],"in":[33,50,69,92,124,263],"immunopathology":[34],"and":[35,55,114,190,205,255],"acute":[36],"distress":[38],"syndrome":[39],"(ARDS)":[40],"Sphingosine-1-phosphate":[42],"(S1P),":[43],"bioactive":[45],"lipid":[46],"mediator,":[47],"crucial":[49],"maintaining":[51],"endothelial":[52,164],"cell":[53],"chemotaxis":[54],"barrier":[56,165],"integrity":[57],"(Table":[58,171,267],"1)":[59],"An":[61],"industry-":[62],"independent":[63],"clinical":[64],"study":[65],"currently":[67],"underway":[68],"China":[70],"investigating":[71],"efficacy":[73],"of":[74,119,144,149,156,161,196,224],"oral":[75],"fingolimod":[76,106,123,178,230],"0":[77],"5":[78],"mg":[79],"(a":[80],"non":[81],"selective":[82],"S1P":[83,237],"receptor":[84,238],"modulator)":[85],"taken":[86],"once-daily,":[87],"for":[88],"three":[89],"consecutive":[90],"days":[91],"patients":[93,125],"with":[94,122,126,177,228],"COVID-19":[95],"Methods:":[97],"Here":[98],"we":[99],"review":[100],"potential":[102,117,200,246],"mechanisms":[103],"which":[105,137],"regulate":[108],"inflammatory":[110],"response":[111],"to":[112,249],"SARS-CoV-2":[113,254],"assess":[115],"benefit-risk":[118,261],"short-term":[120,175,229],"treatment":[121,215,231,247],"COVID-":[127],"19":[128],"experiencing":[129],"ARDS":[130],"Results:":[132],"The":[133,174],"key":[134],"hypotheses":[135],"through":[136],"beneficial":[138],"effects":[139,201],"manifest":[140],"are":[141],"(1)":[142],"attenuation":[143],"via":[147,166],"activation":[148],"serine/threonine":[150],"protein":[151],"phosphatase":[152],"2A":[153],"(PP2A);(2)":[154],"inhibition":[155],"Th17-mediated":[157],"pathway;and":[158],"(3)":[159],"enhancement":[160],"pulmonary":[163],"c-Abl":[167],"tyrosine":[168],"kinase":[169],"pathway":[170],"2)":[172],"intervention":[176],"might":[179],"rapidly":[180],"attenuate":[181],"maladjusted":[182],"responses":[184,189,252],"while":[185],"sparing":[186],"memory":[187],"thus":[191],"has":[192],"relatively":[193],"low":[194],"risk":[195],"infections":[197],"Any":[199],"on":[202],"heart":[203],"rate":[204],"cardiac":[206],"rhythm":[207],"could":[208],"be":[209,233],"managed":[210],"under":[211],"intensive":[213],"care":[214],"setting":[216,265],"Furthermore,":[218],"simulations":[219],"from":[220],"PKPD":[222],"model":[223],"lymphocyte":[225],"count":[226],"data":[227],"will":[232],"presented":[234],"Conclusions:":[236],"modulators,":[239],"such":[240],"as":[241],"fingolimod,":[242],"represent":[244],"option":[248],"ameliorate":[250],"against":[253],"merit":[256],"further":[257],"investigation":[258],"following":[259],"careful":[260],"evaluation":[262],"this":[264],"Presented)":[268]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2020-09-21T00:00:00"}